Atlas Trials

MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

Clinical trial NCT02876172 · COMPLETED

Trial details

NCT number
NCT02876172
Sponsor
Resilient Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Posttraumatic Stress Disorder
Start date
2016-07-03
Primary completion
2017-12-16
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.